Apogem Capital’s KalVista Pharmaceuticals KALV Stock Holding History

Apogem Capital’s Portfolio KALV Stock Details KALV Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$548K	Sell
2022 Q2	$609K	Buy
2022 Q1	$645K	Buy
2021 Q4	$407K	Buy
2021 Q3	$350K	Buy
2021 Q2	$330K	Buy